Clinical trials of PUFAs in depression: State of the art

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Omega-3 Fatty Acid 100%
• Docosahexaenoic Acid 33%
• Fatty Acid 33%
• Icosapentaenoic Acid 33%
• Placebo 33%
• Major Depression 33%
• Bipolar Disorder 33%
• Antidepressant 33%
• Polyunsaturated Fatty Acid 33%
• Drug Administration 33%
• Cardiovascular Disease 33%
• Psychopharmacology 33%
• Depressive Disorder 33%

Neuroscience

• Omega 3 Fatty Acid 100%
• Treatment of Depression 66%
• Docosahexaenoic Acid 33%
• Fatty Acids 33%
• Icosapentaenoic Acid 33%
• Bipolar Disorder 33%
• Placebo 33%
• Antidepressant 33%
• Psychiatry 33%
• Cardiovascular System 33%
• Depressive Disorder 33%
• Polyunsaturated Fatty Acid 33%
• Psychopharmacology 33%

Keyphrases

• Investigator-initiated 33%
• Study Variety 33%